INNV - .1003 Innovus Pharmaceuticals Reports Preliminary Q2 2018 Sales Revenue of $6.6 million to $6.8 million http://stockcharts.com/c-sc/sc?s=INNV&p=D&b=5&g=0&i=t28897493118&r=1531829508093